Synonyms- |
Introduction- |
Target |
Mechanism ALK inhibitors [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date15 Nov 2023 |
Mechanism ALK inhibitors [+4] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date18 Jun 2019 |
Target |
Mechanism TRKA antagonists [+2] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date26 Nov 2018 |
Start Date10 Mar 2023 |
Sponsor / Collaborator |
Start Date27 Dec 2022 |
Sponsor / Collaborator |
Start Date20 Oct 2022 |
Sponsor / Collaborator |